Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cyclerion Therapeutics Inc (NASDAQ: CYCN)

 
CYCN Technical Analysis
5
As on 1st Apr 2026 CYCN SHARE Price closed @ 6.38 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.87 & Strong Buy for SHORT-TERM with Stoploss of 3.36 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CYCNSHARE Price

Open 5.43 Change Price %
High 8.48 1 Day 4.83 311.61
Low 5.39 1 Week 4.79 301.26
Close 6.38 1 Month 5.14 414.52
Volume 252321938 1 Year 4.18 190.00
52 Week High 6.38 | 52 Week Low 1.08
 
NASDAQ USA Most Active Stocks
LPTX 2.05 365.91%
AMRS 0.14 100.00%
WBA 11.98 0.50%
CYCN 6.38 311.61%
WNW 0.06 -25.00%
NVDA 175.75 0.77%
INTC 48.03 8.84%
LMDX 0.02 0.00%
YGMZ 0.02 -66.67%
TIRX 0.03 -50.00%
 
NASDAQ USA Top Gainers Stocks
SPNS 13950.00 32005.87%
SPNS 13950.00 32005.87%
AMRK 3526.00 11954.70%
AMRK 3526.00 11954.70%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
AUUD 5.45 856.14%
CTXRW 0.14 600.00%
LPTX 2.05 365.91%
 
NASDAQ USA Top Losers Stocks
HTOOW 0.00 -100.00%
RELIW 0.00 -100.00%
ARKOW 0.00 -100.00%
LEXXW 0.00 -100.00%
FPAY 0.01 -94.74%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
MAQC 2.00 -81.82%
OTRK 0.07 -78.79%
 
 
CYCN
Daily Charts		 CYCN
Intraday Charts		 Whats New @
Bazaartrend		 CYCN
Free Analysis
 
CYCN Important Levels Intraday
RESISTANCE12.33
RESISTANCE10.42
RESISTANCE9.24
RESISTANCE8.06
SUPPORT4.70
SUPPORT3.52
SUPPORT2.34
SUPPORT0.43
 
CYCN Forecast April 2026
Share
4th UP Forecast18.81
3rd UP Forecast14.82
2nd UP Forecast12.36
1st UP Forecast9.9
1st DOWN Forecast2.86
2nd DOWN Forecast0.4
3rd DOWN Forecast-2.06
4th DOWN Forecast-6.05
 
CYCN Weekly Forecast
4th UP Forecast11.37
3rd UP Forecast9.77
2nd UP Forecast8.78
1st UP Forecast7.79
1st DOWN Forecast4.97
2nd DOWN Forecast3.98
3rd DOWN Forecast2.99
4th DOWN Forecast1.39
 
CYCN Forecast2026
4th UP Forecast20.74
3rd UP Forecast16.13
2nd UP Forecast13.29
1st UP Forecast10.44
1st DOWN Forecast2.32
2nd DOWN Forecast-0.53
3rd DOWN Forecast-3.37
4th DOWN Forecast-7.98
 
 
CYCN Other Details
Segment EQ
Market Capital 114683256.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CYCN Address
CYCN
 
CYCN Latest News
 
Your Comments and Response on Cyclerion Therapeutics Inc
 
CYCN Business Profile
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its product candidates include CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase II trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and Alzheimer's disease with vascular pathology (ADv); Olinciguat, an orally administered vascular soluble guanylate cyclase stimulator that is in Phase II studies for the treatment of sickle cell disease (SCD); Praliciguat, an orally administered systemic sGC stimulator that is in Phase II trials for the treatment of diabetic nephropathy and heart failure with preserved ejection fraction. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service